Clinical Trial Update: The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial updates on the efficacy of Velcade (bortezomib) for bone tissue outcomes in patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Vejle Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED